Abstract
In addition to direct antibacterial actions, 14- and 15-member-ring macrolides have immune modulating effects that appear to be the reason for clinical benefit in diffuse panbronchiolitis. A literature search was conducted for studies of the clinical effectiveness of macrolides in other chronic lung conditions. A number of studies were identified that showed short-term beneficial outcomes or the potential for such outcomes in cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, asthma and post-transplant obliterative bronchiolitis. The studies were limited by small patient numbers, different outcome measures and short-term follow-up, and were not designed to assess potentially harmful effects. Further large prospective and long-term studies are required in order to identify potential benefit and harm before these agents can be recommended routinely for these conditions. Copyright©ERS Journals Ltd 2009.
Original language | English |
---|---|
Pages (from-to) | 171-181 |
Number of pages | 10 |
Journal | European Respiratory Journal |
Volume | 33 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2009 |
Keywords
- Airway
- Anti-inflammatory
- Ketolide
- Macrolide